Non-Obstetric Ultrasound Services

Complete

Value

£1,884,000

Classifications

  • Health services

Tags

  • tender

Submission Deadline

4 years ago

Published

4 years ago

Description

NHS Gloucestershire Clinical Commissioning Group (CCG) seeks expressions of interest from suitably qualified organisations that have the necessary capability and capacity to provide Community Non-Obstetric Ultrasound Diagnostic Services in Gloucestershire.

The NHS supports the need to develop improved access to diagnostic tests as part of the drive to reduce waiting times and improve choice options for Patients. The need to develop community based diagnostic services is supported by the Royal College of Radiologists and Royal College of General Practitioners as part of a service strategy to improve access to tests and ensure these tests are delivered at the right stage of the Patient care pathway. It is important that the use of Community Non-Obstetric Ultrasound (NOUS) is governed by accepted national and locally agreed referral guidelines to maximise the value and cost-effectiveness of this imaging modality in patient management. The service being commissioned is a local community based GP direct access NOUS service with staff qualified to appropriate levels of skill and experience, using equipment which complies with the guidance set by the Royal College of Radiologists, connection to NHS image transfer solutions, the ability to integrate with the e-referral system should this be needed, robust performance management systems and stringent levels of clinical governance. 

The service is expected to undertake 11,780 scans annually.

NHS Gloucestershire CCG is seeking to enter into a contract with the preferred bidder for an initial period of 3-years with an option to extend for a further 2-year period. 

Please note the contract value stated on this advert is for the initial 3-year contract period and is based on current and future expected activity levels, so should be considered as an indicative figure. NHS Gloucestershire CCG expects that the service provided will represent value for money.

The cost envelope range for the delivery of these services is £514,321 to £628,000 per annum. 

Organisations interested in providing this service should register on the In-Tend e-procurement portal (https://in-tendhost.co.uk/gloucestershireccg) and express interest no later than 5pm, Friday 16 April 2021.  Associated Invitation to Tender (ITT) documentation will then be made available for bidding organisations to access.  Completed ITT submissions must be returned via the In-Tend portal no later than noon, Friday 30 April 2021.

Similar Contracts

Open

Provision of Hypertension and Lipids Management Services

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete